1. GPCR/G Protein
  2. Bradykinin Receptor

Bradykinin Receptor

Bradykinin is a potent vasodilator peptide that exerts its vasodilatory action through stimulation of specific endothelial B2 receptors, thereby causing the release of prostacyclin, NO, and EDHF.

Bradykinin (BK) has been reported to be involved in the progression of many types of cancer. Two bradykinin receptors, bradykinin B1 receptor (B1R) and bradykinin B2 receptor (B2R), are significantly expressed in all the tested colorectal cancer cells. Repression of B2R, but not B1R, attenuates the BK-mediated invasion and migration, and inhibits ERK1/2 activation and IL-6 production. Moreover, blocking of the ERK pathway decreases the BK-mediated IL-6 production. In addition, IL-6 repression suppresses the effects of BK on colorectal cancer cell invasion and migration.

Bradykinin, the enzymatic product of kallikrein-kinin system (KKS), is a major modulator of Ang II actions on blood volume, vascular reactivity and salt sensitivity.

Bradykinin Receptor 相关产品 (5):

Cat. No. Product Name Effect Purity
  • HY-17446
    Icatibant Antagonist
    Icatibant(HOE-140)是缓激肽B2受体的高效特异性拮抗剂,IC50和Ki值分别为1.07nM和0.798nM。
  • HY-15043
    ELN-441958 Antagonist 98.94%
    ELN-441958是有效的B1受体拮抗剂, 抑制B1激动剂配体[3H] DAKD与IMR-90细胞结合, Ki值为 0.26 nM, ELN-441958抑制B1受体比作抑制 B2受体具有更高的选择性, 比抑制μ/δ阿片受体选择性分别高500和2000多倍。
  • HY-P0206
    Bradykinin 98.97%
    Bradykinin是由激肽释放酶-激肽系统产生的活性肽。 它是炎症调节因子,也被认为是几种血管和肾功能以及神经调节因子。
  • HY-P0298
    [Des-Arg9]-Bradykinin Agonist
    [Des-Arg9]-Bradykinin 是一种Bradykinin (B1) 受体激动剂,对 B1 受体选择性比B2 受体高。
  • HY-P0272
    Peptide T
    Peptide T是 HIV 入侵的抑制剂,目前在临床试验中用于治疗HIV相关的神经和体征症状。